中文字字幕一区二区三区四区五区 ,少妇av片,69交性视频

產品展示

產品詳情

查看大圖

產品名稱：重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白
產品型號：rHup16-INK4a
產品廠商：KALANG
產品文檔：

你添加了1件商品查看購物車

簡單介紹：

重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白與其它公司提供的重組蛋白不同，rHup16-INK4a蛋白產品為采用CFS的無細胞麥胚蛋白合成系統表達出來的重組蛋白，可表達出對細胞有毒性、易被蛋白酶降解的蛋白；并獲得具有良好的可溶性，并有翻譯后修飾、從而部分具有功能的蛋白.同時獨有的全自動蛋白純化技術則簡便高效，將蛋白純化過程中對蛋白的損傷降低到*小程度.重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白（全長序列）產品可用于Western Blot驗證、抗體制備、蛋白檢測、ELISA等試驗中.

詳情介紹：

重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白

Synonyms CDK4I, MTS-1, p16INK4A

Species Human

Source Escherichia coli.

Molecular Weight Approximately 16.5 kDa, a single non-glycosylated polypeptide chain containing 156 amino acids.

Quantity 10μg/50μg/1000μg

AA Sequence 重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白MEPAAGSSME PSADWLATAA ARGRVEEVRA LLEAGALPNA PNSYGRRPIQ VMMMGSARVA ELLLLHGAEP NCADPATLTR PVHDAAREGF LDTLVVLHRA GARLDVRDAW GRLPVDLAEE LGHRDVARYL RAAAGGTRGS NHARIDAAEG PSDIPD

Purity > 96 % by SDS-PAGE and HPLC analyses.

Biological Activity Data Not Available.

Physical Appearance Sterile Filtered White lyophilized (freeze-dried) powder.

Formulation 重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.

Endotoxin Less than 1 EU/μg of rHuP16-INK4a as determined by LAL method.

Reconstitution We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.

Storage 重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.

重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白

SDS-PAGE

Reference 1. Buda G, Maggini V, Galimberti S, et al. 2007. Leuk Res, 31: 569-70.
2. Komiya A, Suzuki H, Aida S, et al. 1995. Jpn J Cancer Res, 86: 622-5.
3. Jares P, Fernandez PL, Nadal A, et al. 1997. Oncogene, 15: 1445-53.
4. Mori T, Miura K, Aoki T, et al. 1994. Cancer Res, 54: 3396-7.

Background Cyclin-dependent kinase inhibitors (CDKIs) are proteins that bind to and inhibit the activity of CDKs. Two major classes of CDK inhibitors have been identified. The p16 family (p15, p16, p18 and p19) binds to and inhibits the activities of CDK4 and CDK6. The p21 family (p21, p27, p28 and p57) can bind to broad range of CDK-cyclin complexes and inhibit their activities. CDKIs are capable of suppressing growth, and several lines of evidence strongly suggest that at least some CDKIs may be tumor suppressor proteins. p16-INK4A is the member of p16 family and is encoded by CDKN2A gene in humans. It has three isoforms, which are wildly expressed but not detected in brain or skeletal muscle, except that isoform 3 is pancreas-specific. Defects in p16INK4A are a cause of Li-Fraumeni syndrome (LFS) and melanoma-astrocytoma syndrome (MASTS).

標題：

內容：

聯系人：

聯系電話：

Email：

公司名稱：

聯系地址：

注：1.可以使用快捷鍵Alt+S或Ctrl+Enter發送信息!

2.如有必要,請您留下您的詳細聯系方式!

滬公網安備 31011702004399號

Synonyms	CDK4I, MTS-1, p16INK4A
Species	Human
Source	Escherichia coli.
Molecular Weight	Approximately 16.5 kDa, a single non-glycosylated polypeptide chain containing 156 amino acids.
Quantity	10μg/50μg/1000μg
AA Sequence	重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白MEPAAGSSME PSADWLATAA ARGRVEEVRA LLEAGALPNA PNSYGRRPIQ VMMMGSARVA ELLLLHGAEP NCADPATLTR PVHDAAREGF LDTLVVLHRA GARLDVRDAW GRLPVDLAEE LGHRDVARYL RAAAGGTRGS NHARIDAAEG PSDIPD
Purity	> 96 % by SDS-PAGE and HPLC analyses.
Biological Activity	Data Not Available.
Physical Appearance	Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation	重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白Lyophilized from a 0.2 μm filtered concentrated solution in PBS, pH 7.4.
Endotoxin	Less than 1 EU/μg of rHuP16-INK4a as determined by LAL method.
Reconstitution	We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
Storage	重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白This lyophilized preparation is stable at 2-8 °C, but should be kept at -20 °C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8 °C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20 °C to -70 °C. Avoid repeated freeze/thaw cycles.
重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白
SDS-PAGE
Reference	1. Buda G, Maggini V, Galimberti S, et al. 2007. Leuk Res, 31: 569-70. 2. Komiya A, Suzuki H, Aida S, et al. 1995. Jpn J Cancer Res, 86: 622-5. 3. Jares P, Fernandez PL, Nadal A, et al. 1997. Oncogene, 15: 1445-53. 4. Mori T, Miura K, Aoki T, et al. 1994. Cancer Res, 54: 3396-7.
Background	Cyclin-dependent kinase inhibitors (CDKIs) are proteins that bind to and inhibit the activity of CDKs. Two major classes of CDK inhibitors have been identified. The p16 family (p15, p16, p18 and p19) binds to and inhibits the activities of CDK4 and CDK6. The p21 family (p21, p27, p28 and p57) can bind to broad range of CDK-cyclin complexes and inhibit their activities. CDKIs are capable of suppressing growth, and several lines of evidence strongly suggest that at least some CDKIs may be tumor suppressor proteins. p16-INK4A is the member of p16 family and is encoded by CDKN2A gene in humans. It has three isoforms, which are wildly expressed but not detected in brain or skeletal muscle, except that isoform 3 is pancreas-specific. Defects in p16INK4A are a cause of Li-Fraumeni syndrome (LFS) and melanoma-astrocytoma syndrome (MASTS).

一区二区在线免费视频_91精品国产一区二区_一级裸体视频_精品久久网_成人乱码一区二区三区不卡视频_91在线一区

產品名稱：重組人細胞周期蛋白依賴性激酶抑制劑2A，同種型1蛋白